Grade 2 Fatty Liver: What It Means and What to Do Next
“Grade 2 fatty liver” on an ultrasound means a moderate amount of fat in the liver. It does not tell you whether the liver is scarred, which is what actually predicts risk. The next step is a fibrosis check — a FIB-4 blood score and, if needed, a FibroScan. Weight loss reverses it: in one biopsy study, losing 10% or more of body weight resolved steatohepatitis in 90%.
— Dr Chetan Kalal, DM Hepatology, Gleneagles Hospital Mumbai
Key takeaways
- Ultrasound grades (1, 2, 3) describe how much fat is in the liver, not how damaged or scarred it is.
- Ultrasound detects moderate-to-severe fatty liver well — 84.8% sensitivity and 93.6% specificity against biopsy in a meta-analysis of 49 studies — but grading varies between operators.
- Fibrosis stage, not fat grade, decides the long-term risk of cirrhosis and liver cancer, so every Grade 2 report should be followed by a fibrosis assessment.
- In a 293-patient biopsy study, people who lost 10% or more of their weight saw steatohepatitis resolve in 90% and fibrosis regress in 45%.
- Grade 2 fatty liver is usually reversible with weight loss, diet change, exercise and alcohol avoidance.
Few reports cause as much quiet panic in Mumbai as an ultrasound that says “Grade 2 fatty liver”. Patients bring it to me after a routine health check, often with normal liver tests and no symptoms, and the first question is always the same: is this serious? The honest answer is that the report, on its own, cannot tell you. It tells you the liver is holding a moderate amount of fat. Whether that fat is causing damage is a different question, and it has a different test.
Fatty liver — now called MASLD, metabolic dysfunction-associated steatotic liver disease — is the commonest liver condition I see. Most people with it will never develop serious liver disease. A minority, usually those with diabetes, central obesity or long-standing metabolic problems, go on to scarring. This short guide explains what the grade means, what to check next, and what actually reverses it.
What the ultrasound grade does — and does not — tell you
On ultrasound, fat makes the liver look brighter than normal. Radiologists grade that brightness: Grade 1 is mild, Grade 2 moderate, Grade 3 severe, depending on how much the fat obscures the deeper parts of the liver and its blood vessels. A large meta-analysis of 49 studies and 4,720 people found ultrasound detects moderate-to-severe fatty liver accurately compared with biopsy, with a sensitivity of 84.8% and specificity of 93.6%.
Two limits matter. First, grading is subjective: the same scan can be called Grade 1 by one radiologist and Grade 2 by another, and the agreement statistics in that meta-analysis varied widely. Second, and more important, ultrasound brightness does not measure fibrosis. A Grade 1 liver can be scarred; a Grade 3 liver can have no scarring at all. That is why I never make decisions on the grade alone.
| Report | What it means | What to do next |
|---|---|---|
| Grade 1 | Mild fat | Lifestyle change; check metabolic risk factors and FIB-4 |
| Grade 2 | Moderate fat | Lifestyle change; FIB-4, and FibroScan if FIB-4 is not low or you have diabetes |
| Grade 3 | Severe fat | As for Grade 2; specialist review more likely to be useful |
| Any grade with raised liver stiffness | Possible fibrosis | Hepatologist review; treatment and monitoring plan |
The test that matters next: checking for fibrosis
The 2024 European EASL-EASD-EASO guidelines on MASLD build the whole assessment around fibrosis. The first step is usually FIB-4, a score calculated from age, AST, ALT and platelet count — tests most people already have. If FIB-4 is low, the risk of significant scarring is low and lifestyle treatment with periodic review is enough. If it is indeterminate or high, the next step is liver stiffness measurement by FibroScan, which takes ten minutes and needs no needle, or MR elastography in selected cases.
People with type 2 diabetes deserve a lower threshold for testing, because diabetes is one of the strongest drivers of progression from fat to fibrosis. So do people who drink alcohol regularly, since alcohol and metabolic fat damage the liver together.
How Grade 2 fatty liver is reversed
Weight loss is the treatment with the strongest evidence, and the amount matters. In a study of 293 patients with biopsy-proven steatohepatitis followed for a year of lifestyle change, those who lost 5% or more of their weight had steatohepatitis resolution in 58%. Among those who lost 10% or more, steatohepatitis resolved in 90% and fibrosis regressed in 45%. For an 80 kg person, 10% is 8 kg — demanding but achievable over months.
The practical levers are familiar but worth stating precisely. Cut refined carbohydrates and sugar-sweetened drinks, including packaged fruit juices. Watch portion sizes of rice, roti and fried snacks rather than eliminating entire food groups. Build in regular physical activity, with some resistance exercise to protect muscle. Stop alcohol completely if the liver is already fatty. Control diabetes, blood pressure and cholesterol, because those conditions travel with fatty liver and also drive heart disease.
Medicines are reserved for a specific group. In 2026, semaglutide was approved in India for adults with MASH and moderate-to-advanced (F2–F3) fibrosis — not for fat alone. If your fibrosis assessment is reassuring, lifestyle change is the treatment.
When to see a hepatologist
See a liver specialist if your FIB-4 or FibroScan suggests fibrosis, if your liver enzymes stay raised despite lifestyle change, if you have diabetes with fatty liver, if you drink alcohol regularly, or if the ultrasound mentions an irregular liver surface, an enlarged spleen or a liver lump. Our fatty liver clinic at Gleneagles Hospital combines fibrosis staging, metabolic assessment and a written follow-up plan. A repeat scan alone, every few months, without a fibrosis check, rarely changes anything.
Frequently asked questions
Is Grade 2 fatty liver dangerous?
Not by itself. Grade 2 means a moderate amount of fat. The risk depends on whether there is fibrosis (scarring), which ultrasound cannot measure. A FIB-4 blood score and, if needed, a FibroScan tell you whether the liver is being damaged.
Can Grade 2 fatty liver be reversed?
Usually, yes. Weight loss is the most effective treatment. In a biopsy study, patients who lost 10% or more of their body weight had steatohepatitis resolution in 90% and fibrosis regression in 45%.
How accurate is ultrasound for fatty liver?
For moderate-to-severe fat, quite accurate: a meta-analysis found 84.8% sensitivity and 93.6% specificity compared with biopsy. But the grade can vary between radiologists, and ultrasound does not measure scarring.
Do I need medicine for Grade 2 fatty liver?
Most people do not. Medicines such as semaglutide are approved in India for MASH with moderate-to-advanced fibrosis, not for fat alone. If your fibrosis assessment is reassuring, lifestyle change is the treatment.
How often should I repeat the test?
That depends on your fibrosis risk. People with a low FIB-4 and no diabetes usually need only periodic review; people with raised liver stiffness need closer follow-up set by a hepatologist. Repeating ultrasound alone adds little.
Book a consultation with Dr Chetan Kalal at Gleneagles Hospital, Mumbai — call +91 83294 76669 or use the appointment form on this site. International and NRI patients may request a teleconsultation.
References
- Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–1090. PMID 21618575. doi:10.1002/hep.24452
- Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378. PMID 25865049. doi:10.1053/j.gastro.2015.04.005
- European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD: executive summary. Diabetologia. 2024;67(11):2375–2392. PMID 38869512. doi:10.1007/s00125-024-06196-3
